+€100M
Annual revenues
A pharmaceutical manufacturer wanted to achieve ambitious growth targets across three European factories, without massive capital expenditure. Working together with the company’s in-house team, we redefined its industrial footprint and optimized existing operations to accommodate forecasted demand. This transformation freed up cash flow for strategic priorities while building capacity for the future.
Industry: Life Sciences
Service: Manufacturing
Service: Operations Strategy and Transformation
A pharmaceutical manufacturer specializing in widely used products, including aspirin formulations. The company operates as part of a larger pharmaceutical group and maintains a strong presence in the European market. Its manufacturing network spans multiple facilities across Europe, producing essential pharmaceutical products for consumer healthcare markets.
+€100M
Annual revenues
€3B
Parent group turnover
3
European factories
The company faced a critical strategic inflection point with ambitious growth targets that its existing facilities couldn’t accommodate, and that seemed to require massive capital investments.
The operational transformation enabled the company to achieve substantial growth through optimization rather than expansion.
By enhancing production capabilities and redefining its industrial strategy, the company gained both immediate capacity improvements and long-term strategic flexibility
20%
Growth achieved without new investments
€300M
Investments postponed by three years
€60M
Reduced first-phase expansion cost
We re-examined the entire product portfolio to determine optimal manufacturing locations and methods across the three facilities.
We identified opportunities to expand one plant while improving performance, productivity and flows throughout the network.
The team developed a new industrial footprint with a phased investment strategy supporting targeted growth. We assessed improvement potential in current performance, identified where expansions would eventually be needed and pinpointed opportunities to optimize and enhance productivity.
This comprehensive analysis revealed that optimization could delay major investments while still achieving significant growth.
We continue to support the company in implementing its strategic industrial plan, ensuring sustainable transformation through knowledge transfer and capability building.